Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis
Open Access
- 11 June 2010
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 69 (7), 1275-1280
- https://doi.org/10.1136/ard.2009.126888
Abstract
This 9-month open-label extension of the Circadian Administration of Prednisone in Rheumatoid Arthritis Study (CAPRA 1) investigated the long-term safety and efficacy of prednisone chronotherapy with a novel modified-release (MR) prednisone for up to 12 months. Of 288 patients with rheumatoid arthritis originally randomised to MR or immediate-release (IR) prednisone, 249 continued with prednisone chronotherapy (2–10 mg/day) in the 9-month open-label extension. Duration of morning stiffness of the joints (MS), disease activity scores (DAS28), American College of Rheumatology (ACR20) responses and plasma levels of interleukin 6 (IL-6) were assessed. Safety was analysed from adverse event reports and laboratory investigations. During the 3-month double-blind phase, patients in the MR group achieved a reduction in MS of 33.1% while no change was observed in the IR group. After 6 months of treatment, MS was reduced in the IR/MR group by 54% and in the MR/MR group by 56%. MS reduction after 12 months was 45% (IR/MR group) and 55% (MR/MR group). Plasma levels of IL-6 declined on MR treatment. DAS28 was reduced from 5.8 to 4.8 (MR/MR group) and 4.9 (IR/MR group), respectively. 37% of the 219 patients who completed the 12-month study achieved improvement according to the ACR20 criteria. Adverse events did not differ from the known profile of low-dose prednisone. Prednisone chronotherapy with the MR tablet was safe and well tolerated and provided a sustained improvement which resulted in a better benefit to risk ratio of low-dose glucocorticoid treatment for at least 12 months.Keywords
This publication has 18 references indexed in Scilit:
- Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release PrednisoneThe Journal of Rheumatology, 2010
- Polymyalgia rheumatica vs late-onset rheumatoid arthritisRheumatology, 2008
- Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritisRheumatology, 2008
- Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2008
- Circadian rhythms in rheumatoid arthritis: Implications for pathophysiology and therapeutic managementArthritis & Rheumatism, 2007
- Revisiting the Toxicity of Low‐Dose GlucocorticoidsAnnals of the New York Academy of Sciences, 2006
- Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptomsAutoimmunity Reviews, 2005
- Circadian rhythms in RAAnnals Of The Rheumatic Diseases, 2003
- Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988